DISCLOSEDQuarterly
Oaktree Capital Management
Sarepta Therapeutics Inc · NASDAQ
6,709,000 sh · $6.3M
Filed 30 Jun 2026SEC 13Fview source
Oaktree Capital Management
Sarepta Therapeutics Inc · NASDAQ
6,709,000 sh · $6.3M
Oaktree Capital Management
Sarepta Therapeutics Inc · NASDAQ
34,930,000 sh · $30.8M
Oaktree Capital Management
Sarepta Therapeutics Inc · NASDAQ
4,920,000 sh · $3.6M
BlackRock
Sarepta Therapeutics Inc · NASDAQ
37,400,000 sh · $48.1M